QUOTED. 1 July 2019. Rick Gonzalez.
AbbVie is set to enter the medical aesthetics space with its surprise announcement to buy Allergan for about $63bn in a cash and stock transaction. See what AbbVie's CEO Rick Gonzalez said about it here.
"With increasing interest and acceptability of aesthetic procedures and products globally and increasing utilization within younger demographics, the medical aesthetics market has the potential to double by 2025, making this franchise extremely attractive and durable for AbbVie." – Rick Gonzalez, CEO, AbbVie
Click here for a free trial of Medtech Insight